PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $931,638 | +436.8% | 301,501 | +681.7% | 0.00% | – |
| Q2 2023 | $173,561 | +56.7% | 38,569 | +110.4% | 0.00% | – |
| Q4 2022 | $110,725 | -89.6% | 18,332 | -88.6% | 0.00% | – |
| Q3 2022 | $1,064,000 | -49.9% | 160,934 | -60.4% | 0.00% | – |
| Q2 2022 | $2,123,000 | +38.3% | 406,823 | +83.0% | 0.00% | – |
| Q1 2022 | $1,535,000 | -11.0% | 222,298 | +60.5% | 0.00% | – |
| Q4 2021 | $1,725,000 | +280.8% | 138,500 | +855.5% | 0.00% | – |
| Q3 2021 | $453,000 | -46.4% | 14,495 | -25.7% | 0.00% | – |
| Q1 2021 | $845,000 | -74.7% | 19,496 | -82.4% | 0.00% | -100.0% |
| Q3 2020 | $3,341,000 | – | 110,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $124,994,000 | 1.61% |
| Baker Brothers Advisors | 10,123,824 | $126,042,000 | 0.61% |
| Pinz Capital Management, LP | 43,800 | $545,000 | 0.21% |
| HHLR ADVISORS, LTD. | 583,333 | $7,262,000 | 0.11% |
| Rock Springs Capital Management LP | 368,959 | $4,594,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 20,350 | $253,000 | 0.08% |
| Virtus ETF Advisers LLC | 13,815 | $172,000 | 0.06% |
| PDT Partners, LLC | 35,907 | $447,000 | 0.03% |
| Jump Financial, LLC | 36,900 | $459,000 | 0.03% |
| Parkwood LLC | 12,667 | $158,000 | 0.03% |